共 26 条
[1]
Antiangiogenic and antitumor activity of antiepidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells. Ciardiello F,Bianco R,Damiano V,et al. Clinical Cancer Research . 2000
[2]
Pilot trial of ZD1839 (Irresa), an oral inhibitor of epidermal growth factor receptor (EGFR)tyrosine kinase, in combination with carboplatin(C) and paclitaxel(P) in previously untreated advanced non-small cell lung cancer(NSCLC). Laurie SA,Miller VA,Johnson D,et al. Lung Cancer . 2000
[3]
On receptor inhibitors and chemotherapy. Ryan PD,Chabner BA. Clinical Cancer Research . 2000
[4]
Blockade of growth factor receptors in ductal carcinoma in situ inhibits epithelial proliferation. Chan KC,Knox WF,Gandhi A,et al. British Journal of Surgery . 2001
[5]
Synergistic antitumor activity of IFNαin combination with ZD1839 ( IressaTM ), an EGFR tyrosine kinase inhibitor, in HNSCC and melanoma cell lines. Budillon A,Di Gennaro E,Bruzzese F,et al. Clinical Cancer Research . 2000
[6]
Epidermal growth factor receptor blockede with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing othotopically in nude mice by antiangiogenic mechanisms. Bruns C,Harbison M,Davis D,et al. Clinical Cancer Research . 2000
[7]
Targeted therapy with C225 and cisplatin in patients with head and neck cancers. Mendelson J,Shin DM,Donato N,et al. Clinical Cancer Research . 2001
[8]
Antitumor effects of doxorubicin in combination with anti-epidernal growth factor receptor monoclonal antibodies. Baselga J,Norton L,Masui H,et al. Journal of the National Cancer Institute . 1993
[9]
Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by coadministration of ZD1839 ( Iressa), an inhibitor of EGFR tyrosine kinase. Sirotnak F,Zakowski M,Miller V,et al. Clinical Cancer Research . 2000
[10]
Evaluation of ZD1839 (Irresa) alone and in combination with irinotecan ( CPT-11 ) against pediatric solid tumor xenografts. Houghton PJM Cheshire PJ,Harwood FC. Clinical Cancer Research . 2000